Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: Risk stratification based on clinical variables
- 1 February 1985
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 55 (4) , 372-374
- https://doi.org/10.1016/0002-9149(85)90378-9
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Amiodarone: Electrophysiologic actions, pharmacokinetics and clinical effectsJournal of the American College of Cardiology, 1984
- Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillationThe American Journal of Cardiology, 1983
- Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: Long-term follow-upAmerican Heart Journal, 1983
- Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.Circulation, 1983
- Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.Circulation, 1983
- Amiodarone in Refractory Life-Threatening Ventricular ArrhythmiasAnnals of Internal Medicine, 1983
- Amiodarone for control of sustained ventricular tachyarrhythmia: Clinical and electrophysiologic effects in 51 patientsThe American Journal of Cardiology, 1982
- AmiodaroneNew England Journal of Medicine, 1981
- Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone.Circulation, 1981
- Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmiasPublished by Oxford University Press (OUP) ,1979